Keyphrases
Acute Coronary Syndrome
19%
Adverse Cardiac Events
33%
Antihypertensive Medication
28%
Balloon
9%
Bifurcation Lesion
22%
Bleeding
11%
Blood Pressure
17%
Catheter-based Renal Denervation
17%
Clinical Application
12%
Clinical Outcomes
14%
Confidence Interval
21%
Coronary Bifurcation Lesions
24%
Coronary Lesions
15%
Coronary Revascularization
11%
Delayed Revascularization
24%
Diastolic Blood Pressure
13%
Diastolic Function
22%
E Wave
20%
Elective Percutaneous Coronary Intervention
16%
Fractional Flow Reserve
84%
High Risk
15%
In-stent Restenosis
10%
Instantaneous Wave-free Ratio
49%
Intravascular Ultrasound
53%
Jailed Balloon Technique
16%
Left Ventricular End-diastolic Pressure
30%
Left Ventricular Function
27%
Long-term Clinical Outcome
18%
Model-based Image Processing
16%
Myocardial Infarction
19%
Percutaneous Coronary Intervention
65%
Phase Plane
16%
Phase Plane Analysis
10%
Physiologic
10%
Pressure Contour
10%
Randomized Clinical Trial
9%
Renal Artery
10%
Renal Denervation
31%
Resistant Hypertension
16%
Restenosis
13%
Revascularization
40%
Same-day Discharge
16%
Sham Control
28%
Side Branch
12%
Symplicity
16%
Systolic Blood Pressure
35%
Target Lesion Revascularization
15%
Transmitral Flow
19%
Ultrasound-guided Treatments
9%
Uncontrolled Hypertension
11%
Medicine and Dentistry
Acute Coronary Syndrome
20%
Acute Kidney Injury
8%
Antihypertensive Agent
26%
Bleeding
13%
Blood Pressure
21%
Cannulation
8%
Cardiac Catheterization
12%
Cardiac Physiology
8%
Cardiogenic Shock
10%
Cardiovascular System
15%
CATH
8%
Congestive Heart Failure
10%
Coronary Artery
10%
Coronary Artery Disease
19%
Coronary Artery Obstruction
9%
Coronary Bifurcation Lesion
24%
Denervation
8%
Diastolic Blood Pressure
13%
Diastolic Function
26%
Exercise
8%
Fractional Flow Reserve
84%
Hazard Ratio
12%
Health Care Cost
21%
Heart Left Ventricle Enddiastolic Pressure
11%
Heart Left Ventricle Pressure
18%
Heart Muscle Revascularization
11%
Hemodynamic
21%
In-Stent Restenosis
11%
Intravascular Ultrasound
53%
Kidney Denervation
33%
Laser Angioplasty
8%
Left Coronary Artery
8%
Major Adverse Cardiac Event
22%
Maturity Onset Diabetes of the Young
8%
Minimal Effective Dose
25%
Myocardial Infarction
28%
Pediatrics
8%
Percutaneous Coronary Intervention
100%
Randomized Clinical Trial
9%
Renal Artery
17%
Restenosis
13%
Revascularization
72%
Rheumatoid Arthritis
8%
Sex Difference
8%
Smooth Muscle
8%
Stable Angina Pectoris
8%
Stenting
24%
Systolic Blood Pressure
27%
Target Lesion Revascularization
17%
Thorax Injury
8%
